Xiaoqing Guo

7PUBLICATIONS
24CO-AUTHORS
Molecular targetsHaematological tumoursPredictive and prognostic markersLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 19, 2025
Suppressor of TCR signaling 2 (Sts-2) as a potential immunotherapy target and prognostic biomarker in cervical cancer.

Yinlong Chen, Qin Chen, Xiaoqing Guo

|Mar 19, 2025
Tumor Cell-Expressed Herpesvirus Entry Mediator Regulates Proliferation and Adaptive Immunity in Ovarian Cancer.

Yun Lu, Yijun Zhang, Wenxuan Li

|Mar 24, 2024
Intraoperative frozen section pathology of vaginal margin in radical hysterectomy on the prognosis and quality of life for patients with IB2-IIA2 cervical cancer: study protocol for a multicenter randomized controlled trial.

Yu Liu, Weijuan Xin, Ping Wang

|Nov 25, 2022
Intraoperative frozen pathology exam of Common iliac lymph nodes and Para-Aortic lymphadenectomy on the prognosis and quality of life for patients with IB2-IIA2 Cervical Cancer: trial protocol for a randomized controlled trial (C-PACC trial).

Xinyu Qu, Junjun Qiu, Lili Jiang

|Apr 03, 2020
Myeloid-derived suppressor cells promote epithelial ovarian cancer cell stemness by inducing the CSF2/p-STAT3 signalling pathway.

Xiaofeng Li, Jiapo Wang, Weimin Wu

|May 07, 2019
PMS2 germline mutation c.943C>T (p.Arg315*)-induced Lynch syndrome-associated ovarian cancer.

Xiaoqing Guo, Weimin Wu, Hao Gao

Pageof 2

Frequent Collaborators

2 joint publications

Keqin Hua

1 joint publications

Xinyu Qu

1 joint publications

Junjun Qiu

1 joint publications

Lili Jiang